About Y+L amino acid transporter 2
Y+L amino acid transporter 2 (SLC7A6) is a protein
from Homo sapiens identified by UniProt accession
Q92536, 515 residues long.
MolForge cross-references it against 0 known binders and
69 disease associations.
Target properties
| Protein name | Y+L amino acid transporter 2 |
| UniProt accession | Q92536 |
| Gene | SLC7A6 |
| Organism | Homo sapiens |
| Length | 515 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (69)
Diseases linked to this target (Open Targets).
- blood metabolite measurement · score 0.33
- serum metabolite measurement · score 0.31
- glomerular filtration rate · score 0.31
- metabolite measurement · score 0.21
- glioblastoma multiforme · score 0.18
- breast adenocarcinoma · score 0.18
- body mass index · score 0.14
- self reported educational attainment · score 0.14
- creatinine measurement · score 0.13
- lymphocyte count · score 0.12
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q92536-F1 | alphafold | PREDICTED | 83.22 | — |
Amino-acid sequence (515 residues)
MEAREPGRPT PTYHLVPNTS QSQVEEDVSS PPQRSSETMQ LKKEISLLNG VSLVVGNMIG SGIFVSPKGV LVHTASYGMS LIVWAIGGLF SVVGALCYAE LGTTITKSGA SYAYILEAFG GFIAFIRLWV SLLVVEPTGQ AIIAITFANY IIQPSFPSCD PPYLACRLLA AACICLLTFV NCAYVKWGTR VQDTFTYAKV VALIAIIVMG LVKLCQGHSE HFQDAFEGSS WDMGNLSLAL YSALFSYSGW DTLNFVTEEI KNPERNLPLA IGISMPIVTL IYILTNVAYY TVLNISDVLS SDAVAVTFAD QTFGMFSWTI PIAVALSCFG GLNASIFASS RLFFVGSREG HLPDLLSMIH IERFTPIPAL LFNCTMALIY LIVEDVFQLI NYFSFSYWFF VGLSVVGQLY LRWKEPKRPR PLKLSVFFPI VFCICSVFLV IVPLFTDTIN SLIGIGIALS GVPFYFMGVY LPESRRPLFI RNVLAAITRG TQQLCFCVLT ELDVAEEKKD ERKTD
Explore Y+L amino acid transporter 2 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets